PATENT CLAIM ANALYSIS

Application Number: 15892973
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "685000"]

Abstract:
Methods for the treatment of mood disorders and/or skin disease or damage (eczema, atopic dermatitis, or wrinkles, for example) can comprise administering an extracted prenylflavonoid to a subject experience the mood disorder or the skin disease or damage.

Claim (Index 18):
The method of  claim 1 , wherein the method is used to treat a mood disorder and wherein the mood disorder is selected from a group consisting of depression, dysthymia, generalized anxiety disorder, cognitive dysfunction, impaired memory, mental fatigue, physical fatigue, emotional imbalance, occupational stress, insomnia, dysregulation of Circadian rhythm, antisocial behavior, and combinations thereof.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 88.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14791181', '14419633', '14016265', '12654596', '11928917']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660650246495357
- 35 USC 102 Novelty (BERT): 0.4852991675090615
- Combined Prediction Score: 0.7379884389354883
- Mean Citation Score: 127.86551
- Max Citation Score: 147.35075
- Similarity Product: 94.5783603877723

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test